- Home
- SCOR vs AKTX Comparison
SCOR vs AKTX Comparison
Compare SCOR & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- AKTX
- Stock Information
- Founded
- SCOR 1999
- AKTX N/A
- Country
- SCOR United States
- AKTX United States
- Employees
- SCOR N/A
- AKTX N/A
- Industry
- SCOR Business Services
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- AKTX Health Care
- Exchange
- SCOR Nasdaq
- AKTX Nasdaq
- Market Cap
- SCOR 34.7M
- AKTX 29.5M
- IPO Year
- SCOR 2007
- AKTX N/A
- Fundamental
- Price
- SCOR $6.74
- AKTX $0.99
- Analyst Decision
- SCOR Buy
- AKTX
- Analyst Count
- SCOR 3
- AKTX 0
- Target Price
- SCOR $12.83
- AKTX N/A
- AVG Volume (30 Days)
- SCOR 16.9K
- AKTX 80.4K
- Earning Date
- SCOR 11-12-2024
- AKTX 02-15-2025
- Dividend Yield
- SCOR N/A
- AKTX N/A
- EPS Growth
- SCOR N/A
- AKTX N/A
- EPS
- SCOR N/A
- AKTX N/A
- Revenue
- SCOR $356,212,000.00
- AKTX N/A
- Revenue This Year
- SCOR N/A
- AKTX N/A
- Revenue Next Year
- SCOR $2.92
- AKTX N/A
- P/E Ratio
- SCOR N/A
- AKTX N/A
- Revenue Growth
- SCOR N/A
- AKTX N/A
- 52 Week Low
- SCOR $4.89
- AKTX $0.90
- 52 Week High
- SCOR $20.97
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- SCOR 41.86
- AKTX 31.38
- Support Level
- SCOR $6.78
- AKTX $0.95
- Resistance Level
- SCOR $7.30
- AKTX $1.13
- Average True Range (ATR)
- SCOR 0.44
- AKTX 0.15
- MACD
- SCOR -0.16
- AKTX 0.02
- Stochastic Oscillator
- SCOR 4.41
- AKTX 15.15
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).